


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-12.32%
+2.74%
+19.01%
-2.18%
+72.29%
UNH
UnitedHealth Group Incorp
$284.37
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Outperform the market
Risk Analysis

Investors losing their confidence

High risk of cutting its dividend
UNH Price Performance
$338.96 (-16.11%)
$320.52 (-11.28%)
$336.69 (-15.54%)
$474.96 (-40.13%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a weak earnings

Revenue declined YoY

Eps growth

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence

High risk of cutting its dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
UNH Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
UNH Street Sentiment is unimpressive and have negative views on the near-term outlook
UNH has Low risk level
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Today
Reiterate
an Overweight
Mizuho
Jan 22, 2026
Reiterate
its Buy
Mizuho
Jan 08, 2026
Price Target Raised
Buy
Barclays
Oct 30, 2025
Reiterate
Buy
UBS
Oct 30, 2025
Reiterate
Overweight
Piper Sandler
What is UNH current stock price?
What are UNH stock strengths?
What is UNH Risk Level?
What is UNH market cap and volume?
What is UNH current Stock IQ?
Should I buy UNH stock right now?
Is UNH a Strong Buy right now?
What does a 'Strong Buy' rating mean for UNH?
What does a 'Strong Sell' rating mean for UNH?
What factors influence UNH's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-12.32%
+2.74%
+19.01%
-2.18%
+72.29%
UNH
UnitedHealth Group Incorp
Current Price
$284.37

UNH Price Performance
$338.96 (-16.11%)
$320.52 (-11.28%)
$336.69 (-15.54%)
$474.96 (-40.13%)
UNH Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a weak earnings

Revenue declined YoY

Eps growth

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence

High risk of cutting its dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
UNH Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
UNH Street Sentiment is unimpressive and have negative views on the near-term outlook
UNH has Low risk level
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Today
Reiterate
an Overweight
Mizuho
Jan 22, 2026
Reiterate
its Buy
Mizuho
Jan 08, 2026
Price Target Raised
Buy
Barclays
Oct 30, 2025
Reiterate
Buy
UBS
Oct 30, 2025
Reiterate
Overweight
Piper Sandler
UNH Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Outperform the market
Risk Analysis

Investors losing their confidence

High risk of cutting its dividend
UNH Latest Analysis
UnitedHealth Group Incorporated (UNH) Strengthens Healthcare Platform Through Optum Expansion. UnitedHealth Group Incorporated (NYSE:UNH) is one of the best long-term retirement stocks. On February 5 Mizuho cut its price target on UnitedHealth (NYSE:UNH) to $350 from $430 but kept an Outperform rating citing a delayed earnings recovery following the companys Q4 results. On February 3 Piper Sandler reiterated an Overweight rating on UnitedHealth Group with [….]
Today
Mizuho Lowers UnitedHealth Group Incorporated (UNH) Target to $350 Maintains Outperform Rating. UnitedHealth Group Incorporated (NYSE:UNH) is included among the 13 Best Roth IRA Stocks to Buy Now. On February 5 Mizuho cut its price recommendation on UnitedHealth Group Incorporated (NYSE:UNH) to $350 from $430 but kept an Outperform rating on the stock. The revision came after the companys Q4 results with the firm pointing to a [….]
Today
Noteworthy Wednesday Option Activity: UNH LNG BE. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in UnitedHealth Group Inc (Symbol: UNH) where a total of 59644 contracts have traded so far representing approximately 6.0 million underlying shares. That amounts to abo
Wed Feb 11, 2026
UnitedHealth: After The Collapse.
Tue Feb 10, 2026
$100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth This Much Today. UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 15 years by 1.72% on an annualized basis producing an average annual return of 13.34%. Currently UnitedHealth Group has a market capitalization of $251.32 billion.Buying $100 In UNH: If an investor had bought $100 of UNH
Tue Feb 10, 2026
UnitedHealth Stock: Is the Market Overreacting to Lower-Than-Expected Medicare Rates?. Key PointsUnitedHealth Group forecasts that for 2026 its revenue will decline by 2%.
Mon Feb 9, 2026
UnitedHealths Q4 Beat Cant Stop the Slide: Should You Let Go Now?. UNH beats Q4 EPS but the stock plunges 21.5% as medical costs spiked margins sank and Medicare reimbursement risk clouded its outlook.
Thu Feb 5, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.